Mackenzie Financial’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,251
| Closed | -$247K | – | 1784 |
|
|
2025
Q1 | $247K | Sell |
28,251
-25,139
| -47% | -$219K | ﹤0.01% | 1450 |
|
|
2024
Q4 | $767K | Buy |
53,390
+21,817
| +69% | +$313K | ﹤0.01% | 1016 |
|
|
2024
Q3 | $713K | Buy |
+31,573
| New | +$713K | ﹤0.01% | 939 |
|
|
2024
Q2 | – | Sell |
-13,405
| Closed | -$503K | – | 1627 |
|
|
2024
Q1 | $503K | Buy |
+13,405
| New | +$503K | ﹤0.01% | 1021 |
|
|
2022
Q2 | – | Sell |
-4,191
| Closed | -$319K | – | 1549 |
|
|
2022
Q1 | $319K | Sell |
4,191
-11,527
| -73% | -$877K | ﹤0.01% | 1091 |
|
|
2021
Q4 | $2.34M | Sell |
15,718
-6,534
| -29% | -$973K | ﹤0.01% | 744 |
|
|
2021
Q3 | $3.24M | Buy |
22,252
+2,074
| +10% | +$302K | ﹤0.01% | 653 |
|
|
2021
Q2 | $3.95M | Buy |
20,178
+12,831
| +175% | +$2.51M | 0.01% | 599 |
|
|
2021
Q1 | $1.33M | Buy |
7,347
+2,703
| +58% | +$489K | ﹤0.01% | 767 |
|
|
2020
Q4 | $658K | Buy |
+4,644
| New | +$658K | ﹤0.01% | 782 |
|